Page last updated: 2024-09-04

gadolinium dtpa and hydroxychloroquine

gadolinium dtpa has been researched along with hydroxychloroquine in 1 studies

Compound Research Comparison

Studies
(gadolinium dtpa)
Trials
(gadolinium dtpa)
Recent Studies (post-2010)
(gadolinium dtpa)
Studies
(hydroxychloroquine)
Trials
(hydroxychloroquine)
Recent Studies (post-2010) (hydroxychloroquine)
12,6546644,0515,8854744,041

Protein Interaction Comparison

ProteinTaxonomygadolinium dtpa (IC50)hydroxychloroquine (IC50)
Muscarinic acetylcholine receptor M2Homo sapiens (human)2.951
Alpha-1D adrenergic receptorHomo sapiens (human)4.772
Toll-like receptor 9Homo sapiens (human)0.11
Toll-like receptor 7Homo sapiens (human)3.4

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lee, CH; Lee, J; Lee, SK; Song, JH; Suh, JS; Yoon, M1

Trials

1 trial(s) available for gadolinium dtpa and hydroxychloroquine

ArticleYear
Magnetic resonance imaging of the wrist in defining remission of rheumatoid arthritis.
    The Journal of rheumatology, 1997, Volume: 24, Issue:7

    Topics: Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Contrast Media; Evaluation Studies as Topic; Female; Gadolinium DTPA; Humans; Hydroxychloroquine; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Organometallic Compounds; Pentetic Acid; Remission Induction; Remission, Spontaneous; Wrist

1997